The multi N/C analyzer was calibrated for TOC determination between 1 and 500 mg/L using a potassium hydrogen phthalate ...

Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, USA ...

Bionomics Board recommendation The Bionomics Directors continue to unanimously recommend that Bionomics shareholders vote in favor of the Scheme, subject to the Independent Expert continuing to ...

This study presents valuable insights into the organization of second-order circuits for gustatory neurons, particularly how they integrate opposing taste inputs and the metabolic states that regulate ...

Its products, cytisine, is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report).

Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...

Revenues for Q3 2024 were $47.7 million, an increase of 23% compared to Q3 2023Financial Guidance revised for Full Year 2024, raising the midpoint of revenue and cash rangesFanapt® launch in bipolar I ...

Bionomics Limited (Nasdaq: BNOX), a clinical-stage biotechnology company focused on developing novel treatments for central nervous system (CNS) disorders, made waves in the stock market this week.

The brand's success stems from its focused approach to product development, utilising the synergistic benefits of fenugreek ...

This milestone payment from Carina Biotech is another testament to the strong research capabilities which have spawned from Bionomics' scientific expertise, and we are very pleased to receive this ...

Hypoglycemia is an extremely common side effect of insulin therapy experienced mainly by patients with type 1 diabetes ...